Professional Grant Writers

You propose a rational idea to increase the efficiency of scientific research. It is a good one.1 The current focus on grants is destructive, because the fruits of our labor are understanding and dissemination of knowledge. Grants are but a weak surrogate for this activity. Thank you for writing a highly lucid and informative article. We hope it opens a dialogue.George Perry and Mark Smith George Perry, PhDProfessor, Institute of Pathology Case Western Reserve University george.perry@case.eduI e

Written byBen Priest
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

You propose a rational idea to increase the efficiency of scientific research. It is a good one.1 The current focus on grants is destructive, because the fruits of our labor are understanding and dissemination of knowledge. Grants are but a weak surrogate for this activity. Thank you for writing a highly lucid and informative article. We hope it opens a dialogue.

George Perry and Mark Smith George Perry, PhD

Professor, Institute of Pathology Case Western Reserve University george.perry@case.edu

I enjoyed your article on hiring grant writers.1 I agree with your opinion. The progress of science is compromised by grants awarded for "cures of cancer" and "fountains of youth." Indeed, it would be nice to separate creative scientists from "sales-scientists." If a creative scientist came forward with a "salesman trap," we may be able to catch them and study their useful skills. The trap, however, may take forever to build ... ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies